✦ LIBER ✦

Plasma levels of interleukin-12 in drug-naive schizophrenic patients: Changes associated with clinical response to neuroleptic treatment

✍ Scribed by B. Crespo-Facorro; E. Carrasco-Marin; R. Perez-Iglesias; G. Pardo; P. Sanchez-Velasco; F. Leyva-Cobian; J.L. Vazquez-Barquero

Book ID: 119555762
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 115 KB
Volume: 60
Category: Article
ISSN: 0920-9964
DOI: 10.1016/s0920-9964(03)80678-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma homovanillic acid levels and ther

Plasma homovanillic acid levels and therapeutic outcome in schizophrenics: Comparisons of neuroleptic-naive first-episode patients and patients with disease exacerbation due to neuroleptic discontinuance

✍ Kazufumi Akiyama; Kazuo Tsuchida; Akihiro Kanzaki; Hiroshi Ujike; Takashi Hamamu 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 731 KB

Interleukin-12 plasma levels in drug-naï

Interleukin-12 plasma levels in drug-naïve patients with a first episode of psychosis: Effects of antipsychotic drugs

✍ Benedicto Crespo-Facorro; Eugenio Carrasco-Marín; Rocío Pérez-Iglesias; José Mar 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 253 KB

First-episode neuroleptic-free schizophr

First-episode neuroleptic-free schizophrenics: Concentrations of monoamines and their metabolites in plasma and their correlations with clinical responses to haloperidol treatment

✍ Shigeyuki Nagaoka; Norihiko Iwamoto; Heii Arai 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 576 KB

P.3.c.024 Risperidone long-acting formul

P.3.c.024 Risperidone long-acting formulation in treatment-resistant schizophrenic patients: the predictive value of plasma levels in relation to clinical response and safety

✍ G. Cerveri; L.S. Volonteri; I. De Gasperi; B. Papini; P. Papa; M.C. Mauri; C. Me 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Rapid response to paroxetine is associat

Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients

✍ Reiji Yoshimura; Wakako Umene-Nakano; Akihito Suzuki; Nobuhisa Ueda; Kyoko Miyam 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

## Abstract In the present study, we investigated the relationship between the serotonin transporter gene linked polymorphic regions (5‐HTTLPR) or plasma paroxetine levels and clinical response to paroxetine in depressed patients. Sixty patients who met the DSM‐IV criteria for major depressive diso

A phase II randomized, double-blind, pla

A phase II randomized, double-blind, placebo-controlled multicenter study of recombinant human interleukin-12 for the treatment of chronic hepatitis C virus infection in patients non-responsive to previous treatment with interferon-alpha with or without ribavirin: Paul J Pockros, John G McHutchison, Scripps Clinic, La Jolla, CA; Chris O'Brien, University of Miami, Miami, FL; Myron Tong, Huntingon Medical Research Institute, Pasadena, CA; Coleman Smith, Minnesota Clinical Research Center, St. Paul, MN; Vinod Rustgi, Metropolitan Research Group, Fairfax, VA; Robert L Carithers, University of Washington Medical Center, Seattle, WA; Elizabeth Olek, Genetics Institute, Cambridge, MA

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB